⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TIL News
Instil Bio, Inc. Common Stock
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Instil Bio, Inc. - TIL
prnewswire.com
TIL
Bronstein, Gewirtz & Grossman, LLC Encourages Instil Bio, Inc. (TIL) Investors to Inquire about Securities Investigation
accessnewswire.com
TIL
Instil Bio’s Subsidiary Discontinues Clinical Development of AXN-2510 and Terminates License and Collaboration Agreement with ImmuneOnco
globenewswire.com
TIL
Instil Bio Reports Third Quarter 2025 Financial Results and Provides Corporate Update
globenewswire.com
TIL